| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,234 |
3,943 |
$301K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,446 |
1,385 |
$145K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,072 |
1,992 |
$77K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
564 |
562 |
$58K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,021 |
1,678 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
152 |
152 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,104 |
1,075 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
156 |
139 |
$3K |
| 87807 |
|
170 |
168 |
$3K |
| 81003 |
|
557 |
533 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
35 |
35 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$949.74 |
| 81025 |
|
63 |
62 |
$521.57 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
37 |
37 |
$50.51 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
116 |
113 |
$37.91 |
| 3079F |
|
613 |
574 |
$3.71 |
| 3074F |
|
455 |
423 |
$2.77 |
| 3080F |
|
99 |
95 |
$0.75 |
| 3075F |
|
77 |
73 |
$0.24 |
| 3077F |
|
120 |
113 |
$0.00 |
| 3078F |
|
790 |
747 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
362 |
327 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
19 |
18 |
$0.00 |